Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Diseases, Papulosquamous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04882098
What this trial is testing

Guselkumab in Participants With Active Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
Janssen Research & Development, LLC 1,054
Large-scale testing (Phase 3)Study completedNCT02951533
What this trial is testing

Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag G.m.b.H 119
Not applicableStudy completedNCT02376478
What this trial is testing

On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection

Who this might be right for
PsoriasisInflammatory Bowel Diseases
Medical University of Vienna 222
Not applicableEnded earlyNCT04857476
What this trial is testing

Do Patients With Skin Psoriasis Have Sub-clinical Features of Active Psoriatic Arthritis on Musculoskeletal UltraSound?

Who this might be right for
Psoriatic Arthritis
The Royal Wolverhampton Hospitals NHS Trust 8
Not applicableUnknownNCT05767814
What this trial is testing

Optimization of Psoriatic and Seronegative Rheumatoid Arthritis Patients Selection and Treatment Outcomes of Biologic Therapies.

Who this might be right for
Psoriatic ArthritisRheumatoid Arthritis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 135
Testing effectiveness (Phase 2)Study completedNCT01700985
What this trial is testing

Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis

Who this might be right for
PsoriasisPlaque Psoriasis
Therapeutics, Inc. 44
Large-scale testing (Phase 3)Looking for participantsNCT07029516
What this trial is testing

Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis

Who this might be right for
Nail PsoriasisNail DamageMycosis
Wooshin Labottach Co., Ltd. 72
Not applicableUnknownNCT06277635
What this trial is testing

Effect of Silymarin Against Methotrexate-induced Liver Injury in Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisPsoriasis
Phramongkutklao College of Medicine and Hospital 72
Not applicableLooking for participantsNCT07532226
What this trial is testing

Guselkumab Treatment Persistence in Psoriatic Arthritis Participants

Who this might be right for
Arthritis, Psoriatic
Janssen-Cilag Ltd. 200
Early research (Phase 1)Study completedNCT04018599
What this trial is testing

Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

Who this might be right for
Rheumatoid ArthritisPolyarticular Juvenile Idiopathic ArthritisPsoriatic Arthritis+8 more
Fresenius Kabi SwissBioSim GmbH 216
Not applicableStudy completedNCT03738163
What this trial is testing

A Clinical Investigation With Epaderm® Cream

Who this might be right for
EczemaPsoriasisDry Skin; Eczema
Molnlycke Health Care AB 121
Large-scale testing (Phase 3)Study completedNCT03358134
What this trial is testing

Mechanism of Action of Anti-IL17 Therapy in Peripheral Spondyloarthritis

Who this might be right for
Spondylarthropathies
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 20
Large-scale testing (Phase 3)Study completedNCT03066609
What this trial is testing

Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 543
Testing effectiveness (Phase 2)Study completedNCT04855721
What this trial is testing

A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3)

Who this might be right for
Plaque Psoriasis
Aurigene Discovery Technologies Limited 141
Large-scale testing (Phase 3)Not Yet RecruitingNCT06672393
What this trial is testing

Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Hansoh BioMedical R&D Company 375
Not applicableStudy completedNCT05862584
What this trial is testing

Impact of Air Pollution on the Course of Inflammatory Rheumatism

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisPsoriatic Arthritis
Centre Hospitalier Universitaire de Nice 86
Not applicableStudy completedNCT05633264
What this trial is testing

Assess Deucravacitinib Post-marketing Surveillance in Participants With Psoriasis in Japan

Who this might be right for
Psoriasis
Bristol-Myers Squibb 369
Testing effectiveness (Phase 2)Ended earlyNCT00162253
What this trial is testing

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis, Moderate to Severe
Bristol-Myers Squibb 120
Testing effectiveness (Phase 2)Study completedNCT00645892
What this trial is testing

Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 32
Post-approval studies (Phase 4)Study completedNCT05139667
What this trial is testing

Evaluation of Mucoadhesive Tacrolimus Patch on Caspase-3 Inducing Apoptosis in Oral Lichen Planus

Who this might be right for
Oral Lichen Planus
Ain Shams University 30
Next Page